Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)

Clinical trial NCT07423494 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07423494
Sponsor: n-Lorem Foundation
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-03-01
Primary completion: 2027-03-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.